reference/1688096

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1688096

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	359
issn	1557-3265 1078-0432
issueIdentifier	2
pageRange	352-359
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	352
bibliographicCitation	Brave M, Goodman V, Kaminskas E, Farrell A, Timmer W, Pope S, Harapanhalli R, Saber H, Morse D, Bullock J, Men A, Noory C, Ramchandani R, Kenna L, Booth B, Gobburu J, Jiang X, Sridhara R, Justice R, Pazdur R. Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate. Clin Cancer Res. 2008 Jan 15;14(2):352–9. doi: 10.1158/1078-0432.ccr-07-4175. PMID: 18223208.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfa4dbfac34105bf2f830025440f44cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_810b5fdb3eb3cc812ef4b5d5760a6fb5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24a03d20e0082f4a50f829aceeb1bf6d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0729f402514be99d78e528c9fe436cd0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbbbc6271ab9969d4c8ba92117003e4f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70596ce457200c16cfc96490ac619586 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_313073283a77e87a8e0cc36f7f4356e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96cd8005dfab848b49a1a79a7f477b33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8bd41c1c1f83f2092d2dbe42056598d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bda777f996d9aeb8c3eb29e409795819 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e9a8413f0f0360dd99cc87135618403 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53c25c3f39e338fd450f74e04acf7392 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_831130c9bf337fbe5a62e920054a4f97 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7fb015f2f40cd8de1dbf4b00156fdec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01811c43348ce289d25845e178e21473 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c48b6d0a1e0704c40335b649bc0f9c7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3d5fbd9497d4d732e1a1b01b3854f3d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e48f032703cb6b5447f8475b71b0ab8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a58da0f3b7a4dd9e0049f85b1260b1f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1fbf16db6a9e25bef818b471d300399d
date	2008-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1078-0432.ccr-07-4175 https://pubmed.ncbi.nlm.nih.gov/18223208
isPartOf	https://portal.issn.org/resource/ISSN/1078-0432 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1557-3265
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate
discusses	http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0470497 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0021333 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0016884
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010879Q000627 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D015466Q000188 http://id.nlm.nih.gov/mesh/D054198Q000188 http://id.nlm.nih.gov/mesh/D013844Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D017277 http://id.nlm.nih.gov/mesh/D014486 http://id.nlm.nih.gov/mesh/D013844Q000009 http://id.nlm.nih.gov/mesh/D015337 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D013844Q000494 http://id.nlm.nih.gov/mesh/D047428Q000737 http://id.nlm.nih.gov/mesh/D047428Q000009 http://id.nlm.nih.gov/mesh/D017322 http://id.nlm.nih.gov/mesh/D017321 http://id.nlm.nih.gov/mesh/D000970Q000737 http://id.nlm.nih.gov/mesh/D047428Q000494 http://id.nlm.nih.gov/mesh/D011743Q000009 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D013844Q000737 http://id.nlm.nih.gov/mesh/D011743Q000494 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D011743Q000737 http://id.nlm.nih.gov/mesh/D000068877 http://id.nlm.nih.gov/mesh/D000069439 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D014481
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11043 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7078 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8870 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7055 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136

Total number of triples: 90.